IRIS Accounts Production v26.2.0.496 Other Company accounts True false Pounds 1.4.25 31.3.26 31.3.26 FY FRS 102 Independent examiner Small companies regime for accounts Full Charities SORP true true true true false true false true iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh027910562025-03-31027910562026-03-31027910562025-04-012026-03-31027910562024-03-31027910562024-04-012025-03-31027910562025-03-3102791056ns0:CharitableCompanyLimitedByGuarantee2025-04-012026-03-3102791056ns15:PoundSterling2025-04-012026-03-3102791056ns11:FRS1022025-04-012026-03-3102791056ns0:IndependentExaminationCharity2025-04-012026-03-3102791056ns11:SmallCompaniesRegimeForAccounts2025-04-012026-03-3102791056ns11:FullAccounts2025-04-012026-03-3102791056ns0:CharitiesSORP2025-04-012026-03-3102791056ns16:EnglandWales2025-04-012026-03-3102791056ns11:RegisteredOffice2025-04-012026-03-3102791056ns0:Trustee12025-04-012026-03-3102791056ns0:Trustee22025-04-012026-03-3102791056ns11:CompanySecretary12025-04-012026-03-3102791056ns0:TotalUnrestrictedFunds2025-04-012026-03-3102791056ns0:TotalRestrictedIncomeFunds2025-04-012026-03-3102791056ns0:Activity82025-04-012026-03-3102791056ns0:Activity8ns0:TotalUnrestrictedFunds2025-04-012026-03-3102791056ns0:Activity8ns0:TotalRestrictedIncomeFunds2025-04-012026-03-3102791056ns0:Activity82024-04-012025-03-3102791056ns0:TotalUnrestrictedFunds2025-03-3102791056ns0:TotalRestrictedIncomeFunds2025-03-3102791056ns0:TotalUnrestrictedFunds2026-03-3102791056ns0:TotalRestrictedIncomeFunds2026-03-3102791056ns0:TotalUnrestrictedFundsns10:WithinOneYear2026-03-3102791056ns0:TotalRestrictedIncomeFundsns10:WithinOneYear2026-03-3102791056ns10:WithinOneYear2026-03-3102791056ns10:WithinOneYear2025-03-3102791056ns10:PlantMachinery2025-04-012026-03-3102791056ns10:FurnitureFittingsToolsEquipment2025-04-012026-03-3102791056ns10:ComputerEquipment2025-04-012026-03-310279105622025-04-012026-03-310279105612025-04-012026-03-310279105612024-04-012025-03-310279105642025-04-012026-03-310279105642024-04-012025-03-310279105652025-04-012026-03-310279105652024-04-012025-03-3102791056ns10:OwnedAssets2025-04-012026-03-3102791056ns10:OwnedAssets2024-04-012025-03-3102791056ns0:TotalUnrestrictedFunds2024-04-012025-03-3102791056ns0:TotalRestrictedIncomeFunds2024-04-012025-03-3102791056ns0:Activity8ns0:TotalUnrestrictedFunds2024-04-012025-03-3102791056ns0:Activity8ns0:TotalRestrictedIncomeFunds2024-04-012025-03-3102791056ns10:PlantMachinery2025-03-3102791056ns10:FurnitureFittings2025-03-3102791056ns10:ComputerEquipment2025-03-3102791056ns10:FurnitureFittings2025-04-012026-03-3102791056ns10:PlantMachinery2026-03-3102791056ns10:FurnitureFittings2026-03-3102791056ns10:ComputerEquipment2026-03-3102791056ns10:PlantMachinery2025-03-3102791056ns10:FurnitureFittings2025-03-3102791056ns10:ComputerEquipment2025-03-31
REGISTERED COMPANY NUMBER: 02791056 (England and Wales)
REGISTERED CHARITY NUMBER: 1017488













Report of the Trustees and

Unaudited Financial Statements

for the Year Ended 31 March 2026

for

M.K. Multiple Sclerosis Therapy Group
Limited

M.K. Multiple Sclerosis Therapy Group
Limited






Contents of the Financial Statements
FOR THE YEAR ENDED 31 MARCH 2026




Page

Report of the Trustees 1 to 2

Independent Examiner's Report 3

Statement of Financial Activities 4

Balance Sheet 5 to 6

Notes to the Financial Statements 7 to 13

M.K. Multiple Sclerosis Therapy Group
Limited (Registered number: 02791056)

Report of the Trustees
FOR THE YEAR ENDED 31 MARCH 2026


Trustee report for year ended 31st March 2026

The trustees, for the purposes of the Companies Act 2006, present their report with the financial statements of the charity for the year ended 31 March 2026. The trustees have adopted the provisions of the Charities (SORP) FRS102 'Accounting and Reporting by Charities' (effective 1st January 2015).

Principal Activity

The Company was incorporated to provide relief to sufferers of Multiple Sclerosis (MS) from a permanent base in Milton Keynes known as MK Therapy Centre. At the Therapy Centre other conditions are treated, such as Fibromyalgia, Parkinson's, Arthritis, Cancer, Cerebral Palsy (CP), Autism and Sports Injury. Funds for the upkeep of the centre are generated by payment for treatment, fund raising, sponsorship, donations, subscription and grants.

Review of activities

Over the course of this financial year active membership has grown steadily. As of 31/03/2026 there are 55 active members mainly having Hyper-baric Oxygenation Therapy and also Remedial Massage. Therapies provided also include Reiki and Reflexology. In October 2025 we held our AGM and all agreed we needed to raise our prices for all therapies including HBOT. In January 2026 we implemented the price increases for all therapies. The annual subscription stayed the same at £30. It was greeted favourably by members and numbers did not fall significantly. It did, however, show improvement in our finances.

On Friday 16th May 2025 we held our 32nd Open Day celebrating our birthday, trading since 14th May 1993. It was well attended including local MPs, MK Mayor, Wolverton Mayor and Stacey Bushes. Also MS Healthcare Professionals attended. In July we held our Summer Raffle which made a total of £450. At Christmas we held our annual Mince Pie morning with a Christmas Raffle which made £286. In December we held our annual Christmas Lunch at Abbey Hill Golf Club which was well attended and enjoyed by all. Thanks to Laura Jeffs for organising.

Operating Income

Operating income for this accounting period (which includes payments and subscriptions) was £50,578, Donations/fundraising was £3,905. Total Income was £55,848. HBO costs totalled £12,150, Wages were £20,403. Total Expenditure was £56,127. Making a surplus of £1,833.

The Trustees would like to thank the Centre Manager Sharn Nandhra, for her hard work and skill in running the Therapy Centre professionally and smoothly during this financial year. The Trustees would also like to thank the Committee, all the volunteer Operators and Therapists for their work, dedication, support and help in continuing to keep the MK Therapy Centre open and operating safely. Our thanks also go to our Patron, Dr Vasco Fernandes and the Management team, for their continued dedication and support.

STRUCTURE, GOVERNANCE AND MANAGEMENT
Governing document
The charity is controlled by its governing document, a deed of trust, and constitutes a limited company, limited by guarantee as defined by the Companies Act 2006.

The trustees have a duty to identify and review the risks to which the charity is exposed and to ensure appropriate controls are in place to provide reasonable assurance against fraud and error.

REFERENCE AND ADMINISTRATIVE DETAILS
Registered Company number
02791056 (England and Wales)

Registered Charity number
1017488


M.K. Multiple Sclerosis Therapy Group
Limited (Registered number: 02791056)

Report of the Trustees
FOR THE YEAR ENDED 31 MARCH 2026

Registered office
4 Hollin Lane
Stacey Bushes
Milton Keynes
Buckinghamshire
MK12 6HT

Trustees
Ms R Heredia Managing Director
Ms J Bohn Company Secretary

Company Secretary
Ms J Bohn

Independent Examiner
Declan Connolly FCCA
Connolly Accountants & Business Advisors Ltd
Chartered Certified Accountants
The Stable Yard
25-33 Vicarage Road
Stony Stratford
Milton Keynes
Buckinghamshire
MK11 1BN

This report has been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.

Approved by order of the board of trustees on 27 August 2026 and signed on its behalf by:





Ms R Heredia - Trustee

Independent Examiner's Report to the Trustees of
M.K. Multiple Sclerosis Therapy Group
Limited

Independent examiner's report to the trustees of M.K. Multiple Sclerosis Therapy Group Limited ('the Company')
I report to the charity trustees on my examination of the accounts of the Company for the year ended 31 March 2026.

Responsibilities and basis of report
As the charity's trustees of the Company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').

Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's accounts as carried out under Section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under Section 145(5) (b) of the 2011 Act.

Independent examiner's statement
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:

1. accounting records were not kept in respect of the Company as required by Section 386 of the 2006 Act; or
2. the accounts do not accord with those records; or
3. the accounts do not comply with the accounting requirements of Section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; or
4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities (applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)).

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.








Declan Connolly FCCA

Connolly Accountants & Business Advisors Ltd
Chartered Certified Accountants
The Stable Yard
25-33 Vicarage Road
Stony Stratford
Milton Keynes
Buckinghamshire
MK11 1BN

27 August 2026

M.K. Multiple Sclerosis Therapy Group
Limited

Statement of Financial Activities
FOR THE YEAR ENDED 31 MARCH 2026

2026 2025
Unrestricted Restricted Total Total
funds fund funds funds
Notes £    £    £    £   
INCOME AND ENDOWMENTS FROM
Donations and legacies 55,848 - 55,848 43,285

Other trading activities 2 - - - 95
Investment income 3 2,112 - 2,112 2,895
Total 57,960 - 57,960 46,275

EXPENDITURE ON
Raising funds 4 31,915 - 31,915 28,722

Charitable activities
Fundraising 24,031 181 24,212 25,023
Total 55,946 181 56,127 53,745

NET INCOME/(EXPENDITURE) 2,014 (181 ) 1,833 (7,470 )


RECONCILIATION OF FUNDS
Total funds brought forward 105,177 2,901 108,078 115,548

TOTAL FUNDS CARRIED FORWARD 107,191 2,720 109,911 108,078

M.K. Multiple Sclerosis Therapy Group
Limited (Registered number: 02791056)

Balance Sheet
31 MARCH 2026

2026 2025
Unrestricted Restricted Total Total
funds fund funds funds
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 9 1,007 - 1,007 343

CURRENT ASSETS
Debtors 10 2,440 - 2,440 2,303
Cash at bank and in hand 104,670 2,720 107,390 106,314
107,110 2,720 109,830 108,617

CREDITORS
Amounts falling due within one year 11 (926 ) - (926 ) (882 )

NET CURRENT ASSETS 106,184 2,720 108,904 107,735

TOTAL ASSETS LESS CURRENT
LIABILITIES

107,191

2,720

109,911

108,078

NET ASSETS 107,191 2,720 109,911 108,078
FUNDS 13
Unrestricted funds:
General fund 107,191 105,177
Restricted funds:
General Fund Restricted 2,720 2,901
TOTAL FUNDS 109,911 108,078

The charitable company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.


The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.


The trustees acknowledge their responsibilities for
(a)ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company.


M.K. Multiple Sclerosis Therapy Group
Limited (Registered number: 02791056)

Balance Sheet - continued
31 MARCH 2026

These financial statements have been prepared in accordance with the provisions applicable to charitable companies subject to the small companies regime.


The financial statements were approved by the Board of Trustees and authorised for issue on 27 August 2026 and were signed on its behalf by:





R Heredia - Trustee





J Bohn - Trustee

M.K. Multiple Sclerosis Therapy Group
Limited

Notes to the Financial Statements
FOR THE YEAR ENDED 31 MARCH 2026

1. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Income
All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.

Expenditure
Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.


Plant and machinery - 25% on cost
Fixtures and fittings - 3 years
Computer equipment - 3 years

Taxation
The charity is exempt from corporation tax on its charitable activities.

Fund accounting
Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.

Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.

Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to the Statement of Financial Activities on a straight line basis over the period of the lease.


M.K. Multiple Sclerosis Therapy Group
Limited

Notes to the Financial Statements - continued
FOR THE YEAR ENDED 31 MARCH 2026

2. OTHER TRADING ACTIVITIES
2026 2025
£    £   
Shop sales income - 95

3. INVESTMENT INCOME
2026 2025
£    £   
Deposit account interest 2,112 2,895

4. RAISING FUNDS

Raising donations and legacies
2026 2025
£    £   
Rent 11,786 5,825
Rates and water 633 113
Insurance 2,525 2,334
Light and heat 2,038 3,808
Telephone 962 954
Postage and stationery 54 439
HBO costs 12,150 12,306
Fundraising 10 86
Support costs 172 -
30,330 25,865

5. NET INCOME/(EXPENDITURE)

Net income/(expenditure) is stated after charging/(crediting):

2026 2025
£    £   
Depreciation - owned assets 841 491
Rent 11,786 5,825

6. TRUSTEES' REMUNERATION AND BENEFITS

There were no trustees' remuneration or other benefits for the year ended 31 March 2026 nor for the year ended 31 March 2025.


Trustees' expenses

There were no trustees' expenses paid for the year ended 31 March 2026 nor for the year ended 31 March 2025.



M.K. Multiple Sclerosis Therapy Group
Limited

Notes to the Financial Statements - continued
FOR THE YEAR ENDED 31 MARCH 2026

7. STAFF COSTS

The average monthly number of employees during the year was as follows:

2026 2025
Trustees 4 4

No employees received emoluments in excess of £60,000.

8. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES
Unrestricted Restricted Total
funds fund funds
£    £    £   
INCOME AND ENDOWMENTS FROM
Donations and legacies 43,285 - 43,285

Other trading activities 95 - 95
Investment income 2,895 - 2,895
Total 46,275 - 46,275

EXPENDITURE ON
Raising funds 28,722 - 28,722

Charitable activities
Fundraising 24,841 182 25,023
Total 53,563 182 53,745

NET INCOME/(EXPENDITURE) (7,288 ) (182 ) (7,470 )


RECONCILIATION OF FUNDS
Total funds brought forward 112,465 3,083 115,548

TOTAL FUNDS CARRIED FORWARD 105,177 2,901 108,078


M.K. Multiple Sclerosis Therapy Group
Limited

Notes to the Financial Statements - continued
FOR THE YEAR ENDED 31 MARCH 2026

9. TANGIBLE FIXED ASSETS
Fixtures
Plant and and Computer
machinery fittings equipment Totals
£    £    £    £   
COST
At 1 April 2025 48,408 22,947 2,271 73,626
Additions - 305 1,200 1,505
At 31 March 2026 48,408 23,252 3,471 75,131
DEPRECIATION
At 1 April 2025 48,227 22,947 2,109 73,283
Charge for year 181 101 559 841
At 31 March 2026 48,408 23,048 2,668 74,124
NET BOOK VALUE
At 31 March 2026 - 204 803 1,007
At 31 March 2025 181 - 162 343

10. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Prepayments 2,440 2,303

11. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Accrued expenses 926 882

12. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:

2026 2025
£    £   
Within one year 6,447 6,447


M.K. Multiple Sclerosis Therapy Group
Limited

Notes to the Financial Statements - continued
FOR THE YEAR ENDED 31 MARCH 2026

13. MOVEMENT IN FUNDS
Net
movement At
At 1.4.25 in funds 31.3.26
£    £    £   
Unrestricted funds
General fund 105,177 2,014 107,191

Restricted funds
General Fund Restricted 2,901 (181 ) 2,720

TOTAL FUNDS 108,078 1,833 109,911

Net movement in funds, included in the above are as follows:

Incoming Resources Movement
resources expended in funds
£    £    £   
Unrestricted funds
General fund 57,960 (55,946 ) 2,014

Restricted funds
General Fund Restricted - (181 ) (181 )

TOTAL FUNDS 57,960 (56,127 ) 1,833


Comparatives for movement in funds

Net
movement At
At 1.4.24 in funds 31.3.25
£    £    £   
Unrestricted funds 112,465 (7,288 ) 105,177

Restricted fund
General Fund Restricted 3,083 (182 ) 2,901

TOTAL FUNDS 115,548 (7,470 ) 108,078

M.K. Multiple Sclerosis Therapy Group
Limited

Notes to the Financial Statements - continued
FOR THE YEAR ENDED 31 MARCH 2026

13. MOVEMENT IN FUNDS - continued

Comparative net movement in funds included in the above are as follows:

Incoming Resources Movement
resources expended in funds
£    £    £   
Unrestricted funds 46,275 (53,563 ) (7,288 )

Restricted fund
General Fund Restricted - (182 ) (182 )

TOTAL FUNDS 46,275 (53,745 ) (7,470 )

A current year 12 months and prior year 12 months combined position is as follows:

Net
movement At
At 1.4.24 in funds 31.3.26
£    £    £   
Unrestricted funds 112,465 (5,274 ) 107,191

Restricted fund
General Fund Restricted 3,083 (363 ) 2,720

TOTAL FUNDS 115,548 (5,637 ) 109,911

Net movement in funds included in the above are as follows:

Incoming Resources Movement
resources expended in funds
£    £    £   
Unrestricted funds 104,235 (109,509 ) (5,274 )

Restricted fund
General Fund Restricted - (363 ) (363 )

TOTAL FUNDS 104,235 (109,872 ) (5,637 )


M.K. Multiple Sclerosis Therapy Group
Limited

Notes to the Financial Statements - continued
FOR THE YEAR ENDED 31 MARCH 2026

14. RELATED PARTY DISCLOSURES

There were no related party transactions for the year ended 31 March 2026.